AwardedSpainGoods€6,743,304
Suministro de medicamentos exclusivos con principios activos apremilast, carfilzomib, denosumab, etelcalcetida, panitumumab, romiplostim y sotorasib del laboratorio farmaceutico Amgen, S.A., con destino a los centros dependientes del servicio murciano de salud
- Published
- Published 8 May 2025
Overview
Suministro de medicamentos exclusivos con principios activos apremilast, carfilzomib, denosumab, etelcalcetida, panitumumab, romiplostim y sotorasib del laboratorio farmaceútico Amgen, S.A., con destino a los centros dependientes del servicio murciano de salud.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €6,743,304
- Procedure
- Direct
- Published
- 8 May 2025
AntihaemorrhagicsMedicinal products for the musculo-skeletal systemThyroid therapy medicinal productsAntineoplastic agentsImmunosuppressive agents
Award outcome
- Awarded value
- €11,275,964
- Award date
- 28 March 2025
- AMGEN, S.A.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
8 May 2025
Contracting authority
Servicio Murciano de Salud - Junta de Compras
Procuring entityEspinardo, Spain
ID_PLATAFORMA: 41261690169929
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.